Received date: June 30, 2012; Accepted date: August 27, 2012; Published date: August 29, 2012
Citation: Moghaddam AB, Mohammadi A, Mohammadi S (2012) Electroanalysis of Mefenamic Acid in Pharmaceutical Formulation and Spiked Biological Fluids on Modified Carbon Nanotube Electrode. Pharmaceut Anal Acta 3:165. doi: 10.4172/2153-2435.1000165
Copyright: © 2012 Moghaddam AB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Pharmaceutica Analytica Acta
The development of an electrochemical sensor for determination of mefenamic acid is the main purpose of this work. The determination was performed in pharmaceutical formulations, spiked urine and human plasma samples by multi-walled carbon nanotube-graphite/Ag (MWCNTs-G/Ag) electrode. Hence some voltammetric methods were investigated to determination of mefenamic acid. The dependence of peak currents and potentials on pH and voltammetric parameters was investigated for the optimization of electrochemical method. The porous structure of MWCNTs-graphite mixture improves the electroactive surface area. As a result, a remarkable increasing in the peak currents was observed. The prepared mixture displayed an electrocatalytic effect in anodic oxidation of mefenamic acid with a sensitivity augmentation. The best electrochemical response was obtained from square wave voltammetry with a sensitive peak at 0.68 V in pH 5. The prepared electrode showed good standard calibration curves during 3 days over a wide concentration range with RSD values ranging from 1.6-8%. The limits of quantification and detection were 50 and 16 ng/mL, respectively.
Carbon nanotube; Pharmaceutical formulation; Spiked biological fluids; Mefenamic acid
Drug analysis has an important role on public health  and due to extensive use of non-steroidal anti-inflammatory drugs for their devastating effects on pains like: headache, post-operative, dental pain and some diseases including arthritis, sport injuries and other rheumatic diseases, many researches were done for developing of sensitive and rapid technique for the analysis of these drugs . One of these drugs is mefenamic acid, 2-[(2, 3-Dimethylphenyl) amino] benzoic acid . Overdoses of mefenamic acid generate toxic metabolite accretion that causes severe hepatic necrosis, including morbidity and death in patients . Due to the vital importance of mefenamic acid, it is essential to develop a simple, rapid and reliable technique for the determination of mefenamic acid. Spectrophotometric , solid phase extraction , atomic absorption spectrometry , NMR , chromatography [9-13] and flow injection spectrophotometry [14,15] are several analytical methods developed for the determination of mefenamic acid. Electrochemical techniques are extensively applied due to their sensitive properties and usually they do not require sample pretreatment that is time consuming and difficult [16,17].
So, the purpose of this work is to develop a sensor utilizing electrochemical nanotechnology for determination of mefenamic acid by using the simple, inexpensive and reliable technique.
Some electrochemical investigation about mefenamic acid in both redox mechanism field [1,18] and quantitative determination like voltammetry  were also reported. In recent years the modification of electrode substrates with various nanomaterials (e.g. carbon nanotubes and metal oxide nanoparticles) and composite materials has been reported [20-22]. Composite materials typically consist of two or more components that modify the surface of electrodes. There is clear that the potential for several differences in the preparation (the type of carbon, binder and presence of modifiers) can affect the selectivity and sensitivity of electrochemical response of the modified electrode. The binder can be taken a simple mineral oil [23,24], polymers , wax or epoxy , or ionic liquid . Among the carbon allotropes, carbon nanotubes (CNTs) were many applied for modification of electrodes. CNTs have risen to significant importance in recent years and have been extensively examined as electrode modifiers. CNTs are potentially applicable in a various fields like: optics, electronics, analytical science and others. They gained significant attending in electrochemical sensors and biosensors for the making of electrodes . They provided fast electron transfer kinetics and reduced reaction potential.
In the present study, the catalytic activity of MWCNTs-graphite mixture toward the oxidation of mefenamic acid is demonstrated. The results display that MWCNTs-G/Ag electrode shows an efficient electrocatalytic behavior in the electrooxidation of mefenamic acid that leads to a considerable improvement in its anodic peak current. It is successfully applied to achieve a high electroactive surface area for development of an electrochemical sensor to determination of mefenamic acid in pharmaceutical dosage forms and biological fluids. A good linear relationship has been found between the anodic peak current and mefenamic acid concentration in the range of 50−2000 ng/ mL. The limits of quantification and detection were 50 and 16 ng/mL, respectively.
Reagents and materials
Mefenamic acid working standard powder was a gift from Iranian Quality Control Lab, Ministry of Health and Medical Education of Iran. Boric acid, phosphoric acid, acetic acid, sodium hydroxide, ethyl acetate, paraffin oil (density 0.84~0.89) and graphite powder (<50 μm) were all provided from Merck. Multi-walled carbon nanotubes (MWCNTs) prepared by chemical vapor deposition were purchased from Neutrino Co. (Iran). The MWCNTs had an outer wall diameter distribution of <10 nm, a length of between 5-15 μm and a special surface area of 180-190 m2/g and amorphous carbon <3%. All other chemicals were purchased from Merck and used without any further purification. Doubly distilled deionized water was used for all aqueous solution preparations. Britton-Robinson buffer containing 0.04M of each component (acetic acid, phosphoric acid and boric acid), adjusted to the required pH with sodium hydroxide solution (0.2M) and was used as supporting electrolyte. Mefenamic acid capsules, each of containing 250 mg of active ingredient, were purchased from a local pharmacy. Fresh frozen plasma was obtained from Iranian Blood Research and Fractionation Holding Company (IBRFC). Drug free human urine was obtained from healthy volunteers (25-30 years). All experiments were carried out at an ambient temperature of 25 ± 2°C.
A three electrode cell was used for the electrochemical experiments, incorporated a hand-made working MWCNTs-G/Ag electrode using a μ-AUTOLAB TYPE III. A saturated Ag/AgCl/KCl as a reference electrode and platinum wire that was used as a counter electrode. Sonication was achieved using of ultrasonic bath system TECNOGAZ, Tecna 6 (50–60 Hz, 230 ± 10% V, 0.138 KW). Furthermore, a Philips model X-30 scanning electron microscope (SEM) was used to obtain the microscopic image.
Due to our recent studies at investigation of CNTs-graphite mixture for electrochemical studies, different ratios of carbon nanotube and graphite were examined and the best results were obtained in ratio of 1:1, w/w . We found that MWCNTs-G/Ag electrode is useful for determination of mefenamic acid. So, we continued our studies on mefenamic acid by this electrode. In detail, 6 mg from both MWCNTs and graphite were mixed together truly and small amount of paraffin oil (3.6 μL) were added. Afterwards, a portion of the composite mixture was packed into the end of a polytetrafluoroethylene tube. The electrical contact was made by forcing an Ag rod (r=1 mm) into the polytetrafluoroethylene tube and the composite to ensure that a layer of composite was formed on the surface of Ag electrode.
Preparation of stock and standard solutions
Mefenamic acid stock solution (0.2 mg/mL) was prepared by dissolving of mefenamic acid working standard powder in ethanol. Mefenamic acid standard solutions with different concentrations were obtained by diluting the specified volume of stock solution. The solutions were stored in refrigerator at 4°C for maximum three days. Plasma/urine standard solutions (200, 500 and 1000 ng/mL) were prepared by spiking the appropriate amounts of mefenamic acid stock solution with the blank plasma/urine samples.
In this part, 1.0 mL of buffer solution (pH 2.5) was added to 0.5 mL spiked plasma or urine, then the mixture was vortexed for 2 min and afterwards 2 mL ethyl acetate was added and vortexed for 3 minutes. The mixture was centrifuged at 6000 rpm for 5 min to separate the aqueous and organic layers. After separating the organic phase, the extraction procedure was continued on the residual aqueous phase. The ethyl acetate phase was pooled and dried at 60°C under a mild stream of nitrogen. After drying, samples were reconstituted with 20 mL of buffer solution (pH 5) and transferred to electrochemical cell for the analysis.
Capsules assay procedure
The contents of twenty mefenamic acid capsules were weighed and mixed fine. A fractional of powder equivalent to the weight of one capsule was dissolved in 80 mL ethanol into a 100 mL volumetric flask. It was sonicated for 20 min to affect complete dissolution and then made up to volume with ethanol. Suitable aliquots of solution were filtered by a 0.45 μm nylon filter. 40 μL of the filtered solution was added to a 100 mL volumetric flask and made up to volume with Britton-Robinson buffer to yield starting concentration of 1000 ng/mL.
Calibration and method validation
Calibration curves were obtained by plotting anodic peak height against mefenamic acid concentration. Validation parameters including linearity, limit of detection (LOD), limit of quantification (LOQ), precision, accuracy and selectivity were assessed. Square wave voltammograms (SWVs) of mefenamic acid solutions were recorded in a wide range of concentrations (50-2000 ng/mL) in pH 5 at MWCNTs-G/Ag (1:1, w/w).
Characterization of MWCNTs
The scanning electron microscopic image of MWCNTs was recorded and shown in Figure 1. In accordance with this Figure 1, MWCNTs have porous structure. Therefore, prepared MWCNTsgraphite mixture can present porous structure. Paraffin oil could bridge the isolated carbon materials in MWCNTs-graphite mixture.
pH effect on voltammetric responses
The pH of supporting electrolyte has an important influence on electrochemical response of mefenamic acid at the modified electrode. So, we analyzed the pH effect of supporting electrolyte on anodic peak currents and potentials to obtain the maximum sensitivity. Cyclic voltammograms (CVs) and square wave voltammograms (SWVs) of mefenamic acid solutions (1000 ng/mL), were considered in various pH values from 3.0 to 7.0. With comparing the electrochemical techniques in different pH, it was found that the square wave voltammetry is a sensitive technique for determination of mefenamic acid. By overlaying CVs and SWVs in different pH values at MWCNTs-G/Ag electrode, pH 5 was selected as the best pH. Parts (I) and (II) of Figure 2, show CVs and SWVs of mefenamic acid (1000 ng/mL) in pH ranges of 3.0 to 7.0 at MWCNTs-G/Ag electrode, respectively. In accordance to part (I) of Figure 2, anodic peaks from pH 3 to 7 show a regularly shifts about 0.05 V to lower potentials. Inset of this Figure 2 shows the linear relationship between pH values and anodic peak potentials (EPA) that decreased 56 mV per pH unit. This relationship can be described by the equation (1):
EPA (V) = -0.056 pH + 0.979 (R2=0.992)
It shows that the equal number of protons and electrons participate in electrochemical oxidation of mefenamic acid. Part (a) of Figure 3, shows the CVs of 1000 ng/mL mefenamic acid in pH 5 at MWCNTs-G/Ag electrode, while part (b) of this Figure 3, shows the CVs of mefenamic acid at standard glassy carbon electrode. The results show the enhanced electrochemical response of mefenamic acid at MWCNTs-G/Ag electrode compare to glassy carbon electrode. This can be related to the porous structure of MWCNTs-graphite mixture that improves the electroactive surface area.
Effect of scan rate on the peak currents and peak potentials
The effect of scan rate between 40-300 mV/s on the electrochemical response of mefenamic acid at MWCNTs-G/Ag electrode was evaluated by cyclic voltammetry that is shown in part (a) of Figure 4. A slope of 0.676 was obtained for the linear relation between the log IPA and the log υ in part (b) of Figure 4. The regression equation for this relationship is regarding to equation (2):
log IPA = 0.676 log υ – 1.538 (R2=0.996; IPA: μA, υ: mV/s)
Figure 4: (a) Cyclic voltammograms of 1000 ng/mL of mefenamic acid at MWCNTs-G/Ag in buffer solution (pH 5) in various scan rates (from inner to outer); 40, 80, 100, 140, 180, 220, 240, 280 and 300 mV/s. (b) Relationship between the peak currents (Ipa) vs. square root of scan rates (c) Relationship between square root of scan rate and peak potential
The slope value of the double logarithmic plot lies in the range from 0.5–1.0 for the mixed adsorption and diffusion controlled process . This result proves that a mixed adsorption and diffusion controlled mechanism was involved in the mefenamic acid oxidation process at the MWCNTs-G/Ag electrode. The results have shown a positive shift in the anodic peak potentials with the increasing of scan rates. Also, in accordance to part (c) of Figure 4, the plot of anodic peak potentials versus the logarithm of scan rates was linear for mefenamic acid oxidation reaction which confirms the irreversibility of oxidation process on the MWCNTs-G/Ag electrode surface. The regression equation for this relation is according to equation (3):
EP = 39.584 log υ + 614.11 (R2=0.998; EP: mV, υ: mV/s)
The calibration curves for mefenamic acid were found by the results of square wave voltammetric measurements. We know that the derivative techniques such as square wave voltammetry have a good resolving power and lower background current. The SWVs obtained for mefenamic acid with various concentrations that were linear over the concentration range of 50-2000 ng/mL as can be seen in Figure 5. In this Figure 5, anodic current (IPA) of mefenamic acid were plotted against the concentration of mefenamic acid and linear regression analysis completed on the resulting curve. Three correlation coefficients of R1=0.9989, R2=0.9996 and R3=0.9990 with R.S.D. values ranging from 1.6-8 % across the concentration range studied were obtained. Equation (4) is a typically regression equation for the calibration curve.
IPA = 0.2117 C + 3.0755 (R2=0.9996; IPA: μA, C: ng/mL)
LOQ and LOD of the electrode towards mefenamic acid were found to be 50 ng/mL and 16 ng/mL, respectively.
Reproducibility for the developed sensor was investigated by electroanalysis of three samples containing 50, 1000 and 2000 ng/mL standards over 3 consecutive days. The mean concentrations were found to be 46, 1000 and 1996 ng/mL with related %R.S.D. values of 7.5, 3.15 and 3.1, respectively. Accuracy of the assay was determined by interpolation of replicate (n=3) peak areas of three accuracy standards (50, 1000 and 2000 ng/mL) from a calibration curve prepared as previously described. In each case, the percentage of relevant error was calculated. The resultant concentrations were 46 ± 2.8 ng/mL (mean ± SD), 1030 ± 32.4 ng/mL and 2069 ± 34.5 ng/mL with percentage relevant errors of 8.04, 3 and 3.43%, respectively.
Some voltammetric procedures have been reported for the determination of mefenamic acid in pharmaceutical samples and biological fluids. But in accordance with our knowledge there is no report regarding the use of MWCNTs-G/Ag electrode for the determination of mefenamic acid.
We were determined mefenamic acid with LOD value of 16 ng/mL by this electrode. In Table 1 the most important reported electrodes are summarized with their LOD for the determination of mefenamic acid.
|Range of calibration curve||LOD||Electrode type||Reference|
|384-1525 µM||95.9 µM||Nanoparticles of Ni-curcumin-complex modified electrode||1|
|25-476 µM||4.96 µM||Nickel hydroxide-modified nickel electrode||19|
|1-0.01 M||0.62 µM||Mefenamate-sensitive electrode||20|
|0.3-100 µM||0.04 µM||Copper (II) doped zeolite modified carbon paste electrode||21|
|100-20 µM||10 nM||Carbon nanotubes-gold nanoparticles composite film modified electrode||22|
|Multi-walled carbon nanotube: graphite/Ag electrode||This work|
Table 1: Different reported electrodes for determination of mefenamic acid.
Assay of mefenamic acid
The investigated method was applied to the determination of mefenamic acid in a generic brand of mefenamic acid capsules. The result of the assay yielded 103% (%R.S.D.=5%) of label claim for the generic brand capsules. The results of the assay indicate that the method is selective for the assay of mefenamic acid without interference from the excipients used in this capsule.
Recovery of mefenamic acid in capsules
A known amount of mefenamic acid standard was added to aliquots of capsule contents and mixed well. Then the powder was extracted and diluted as previously described to yield a starting concentration of 1200 ng/mL. This solution was analyzed and the concentration of mefenamic acid was found to be 1225 ± 51 ng/mL. The resultant %R.S.D. for this study was found to be 4.16% with a corresponding percentage recovery value of 102.08%.
Determination of mefenamic acid in human plasma
Recoveries from human plasma samples were measured by spiking drug-free samples with known amount of mefenamic acid using developed method for determination of mefenamic acid. Parts (a)-(c) of Figure 6, shows the SWVs of buffer, extracted plasma blank and extracted plasma spiked sample (1000 ng/mL), respectively. It shows that determination of mefenamic acid is accomplished successfully in plasma sample. Three concentrations of mefenamic acid spiked plasma were tested (200, 500 and 1000 ng/mL). The recovery percentages were summarized in Table 2.
|Spiked mefenamic acid||200 ng/mL||500 ng/mL||1000 ng/mL|
|Recovery percent in plasma (mean ± S.D.)||64.5 ± 2.3||84.7 ± 1.8||75 ± 1.5|
|Recovery percent in urine (mean ± S.D.)||84.2 ± 1.8||77.65 ± 1.6||75.5 ± 1.35|
Table 2: Percent recovery for electrochemical determination of mefenamic acid in plasma and human urine (n=3) by MWCNTs-G/Ag electrode.
Determination of mefenamic acid in human urine
Parts (a) and (b) of Figure 7 (I) shows the SWVs of blank urine before and after extraction, respectively. There is a very sharp peak near the range of mefenamic acid potential that interferes in the quantitative analysis. Thus the urine blanks were extracted with ethyl acetate. Parts (a) and (b) of Figure 7 (II) shows the SWVs of urine blank after extraction and extracted urine spiked sample (1000 ng/mL), respectively. Three concentrations of mefenamic acid spiked urine were tested. The recovery percentages were shown in Table 2.
The developed methodology offers a new sensitive electrochemical sensor because of high surface area, excellent electrochemical conductivity and electrocatalytic properties of multi-walled carbon nanotubes. MWCNTs-G/Ag electrode resulted in catalytic effects toward the electro-oxidation of mefenamic acid. A remarkable enhancement in microscopic area of the electrode due to the presence of MWCNTs was observed. This caused increasing of the electrooxidation peak current. So, simple and applicable electrochemical sensor allowed the successful determination of mefenamic acid in capsules. It performed directly without any separation steps and also in biological fluids with good recovery percent and RSD.
The financial support provided by the Tehran University of Medical Sciences Research Affairs is gratefully acknowledged. The authors thank the University of Tehran for the supply of some instruments.